期刊文献+

rAAV-hBMP7的包装纯化及感染滴度的测定

Package and purify the rAAVhBMP_7 virus and infection titer measurement
下载PDF
导出
摘要 目的:包装纯化具有感染性的腺相关病毒rAAV-hBMP7,检测其包装效率及感染滴度。方法:应用AAV Helper-Free System、磷酸钙三质粒共沉淀法,将病毒质粒pAAVIRES-hrG-FP-hBMP7、辅助质粒pAAV-Helper和包装质粒pAAV-RC转染AAV-293细胞,进行病毒包装,荧光计数法测定病毒包装效率;反复冻融收获病毒液,按氯仿处理、PEG/NaCl沉淀的方法浓缩纯化;纯化的病毒液感染AAV-HT1080细胞观测荧光表达,原位β-半乳糖苷酶染色测定病毒感染效率和滴度。结果:转染AAV-293细胞后6h即有绿色荧光表达,包装效率为94.16±0.13%。纯化的rAAV-hBMP7在HT1080细胞中的感染效率为78%,计算病毒物理滴度为2.34×1011v·g/ml。结论:磷酸钙三质粒共沉淀法可实现病毒在AAV-293细胞中的高效包装,纯化的rAAV病毒载体能介导hBMP7基因转染真核细胞并具有较高的转染效率和感染滴度。 Objective: To package and purify the infectious virus which are the recombined adeno-associ- ated viral vector of human bone morphogenetic protein-7(hBMP-7) and testing the packaging efficiency and infection titer. Methods: Application of AAV Helper-Free System and calcium phosphate three plasmid coprecipitation meth- od, the virus plasmid pAAVIRES- hrGFP - hBMP7, auxiliary plasmid pAAV- Helper and packing plasmid pAAV - RC were transfected into AAV-293 cells to virus packaging. Through the repeated freezing and thawing get virus con- centrate. Obtained virus fluid were processed by chloroform precipitate treatment, PEG8000/NaC1 precipitation and chloroform extraction for purification. The purified virus fluid infected HT-1080 cell and observed the fluorescence expression. Virus titer and infection efficiency to HT1080 cells were identified by the in situ beta galactosidase dye- ing. Results: After transfected AAV-293 cells, green fluorescent protein was expressed in 6 hours and the packing efficiency is 94.16%-0.13% the transfected efficiency to AAV-HT1080 cells was 78%. Measuring virus titer is a- bout 2.34 X 1011v. g/ml. Conclusion: Calcium phosphate three plasmid coprecipitation method can realize the virus in AAV-293 cells of the efficient packing. The purified rAAVhBMP7 virus carrier can mediated hBMP7 gene trans- fected eukaryotic cells and has high transfection efficiency and infection titer.
出处 《陕西医学杂志》 CAS 2013年第5期526-531,共6页 Shaanxi Medical Journal
基金 陕西省科学技术研究发展计划项目(2009K17-06)
关键词 病毒 转染 骨形态发生蛋白质类 代谢@重组腺相关病毒 Virus Transfection Bone morphogenetic proteins/metabolism @Recombined adeno-as-sociated viral vector
  • 相关文献

参考文献15

  • 1Wozney JM. Overview of bone morphogenetic proteins [J]. Spine (Phila Pa 1976),2002,27(16 Suppl 1): 2-8.
  • 2St George JA. Gene therapy progress and prospects adeno- viral vectors[R]. GeneTher, 2003, 10 (14): 1135-1137.
  • 3石建峰,李昂,饶国洲,厉强.hBMP-7基因重组腺相关病毒载体的构建及人牙髓细胞转染的研究[J].陕西医学杂志,2008,37(1):73-75. 被引量:2
  • 4Schlance T, Andree B, Arfnold H H, etal. BMP-2 is re- quired for early hears development during a distinct time period[J]. Mech Dev, 2000,91 (1-2) : 259-270.
  • 5Yamazoe T, Aoki K, Simokawa H, et al. Gene expres- sion of bone matrix proteins in a calcified tissue appeared in subcutaneously transplanted rat dental pulp[J] . J Med Dent Sci,2002, 49(1): 57-66.
  • 6J in QM,Anusaksathion O, Webb SA, et a l. Gene therapy of bone morphogenetic protein for periodontal tissue en- gineering[J]. J Periodontol, 2003,74 (2) : 202-213.
  • 7Yeh LC,Lee JC. Co-transfection with the osteogenic pro- tein(OP)-I gene and the insulin-like growth factor(IGF)- 1 gene enhanced osteoblastic cell differentiation[J]. Bio- chim Biophys Acta ,2006,1763(1) :57-63.
  • 8McCarty D M. Self- complementary AAV vectors; Ad- vances and applications[J] . Mole Ther , 2008, 16(10): 1648-1656.
  • 9Kunze M, Huber A, Krajewski A, et al. Efficient gene transfer to periodontal ligament cells and human gingival fibroblasts by adenoassociated virus vectors[J]. J Dent, 2009,37(7) : 502-508.
  • 10Bainbridge J W,Smith A J,Barker S S,et al. Effect of gene therapy on visual function in Leber's congenital am- aurosis[J]. N Engl J Med,2008,358(3) : 2231-2239.

二级参考文献47

  • 1杨民,马庆军,郭均,党耕町.重组人骨形态发生蛋白7的腺相关病毒载体的构建[J].中国骨与关节损伤杂志,2005,20(7):458-461. 被引量:2
  • 2Manno CS, Pierce GF, Arruda VR, et al. Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response. Nat Meal, 2006, 12(3): 342 347.
  • 3Mingozzi F, Maus MV, Hui DJ, et al. CD8+ T-cell responses to adeno-associated virus capsid in humans. Nat Meal, 2007, 13(4): 419-422.
  • 4Madsen D, Cantwell ER, O'Brien T, et al. Adeno-associated virus serotype 2 induces cell-mediated immune responses directed against multiple epitopes of the capsid protein VPI. J Gen Virol, 2009, 90(11): 2622-2633.
  • 5Wright JF. Transient transfection methods for clinical adeno-associated viral vector production. Hum Gene Ther, 2009, 20(7): 698-706.
  • 6Chadeuf G, Ciron C, Moullier P, et al. Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery. Mol Ther, 2005, 12(4): 744- 753.
  • 7Li CW, Hirch M, Asokan A, et al. Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector transduced cells coexpressing the AAV2 capsid in vivo. J Virol, 2007, 81(14): 7540-7547.
  • 8Wang LL, Figueredo J, Calcedo R, et al. Cross-presentation of adeno-associated virus serotype 2 capsids activates cytotoxic T-cells but does not render hepatocytes effective cytolytic targets. Hum Gene Ther, 2007, 18(3): 185-194.
  • 9Wang XS, Khuntirat B, Qing K, et al. Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination. J Virol, 1998, 72(7):5472-5480.
  • 10Nony P, Chadeuf G, Tessier J, et al. Evidence for packaging of rep-cap sequences into adeno-associated virus (AAV) type 2 capsids in the absence of inverted terminal repeats: a model for generation of rep-positive AAV particles. J Virol, 2003, 77(1): 776-781.

共引文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部